Effectiveness and Cost Effectiveness of OkeyMind for Social Anxiety Among Youth
Launched by HONG KONG SHUE YAN UNIVERSITY · Jun 29, 2024
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background: Social anxiety is increasingly prevalent among youths, leading to social withdrawal and isolation, which heighten depression risk. eHealth interventions have shown promise in improving access and engagement, offering anonymity, broader accessibility, and personalized treatment features. However, the effectiveness and cost-effectiveness of eHealth methods for young individuals dealing with social anxiety-driven depression remain unexplored.
Objective: This randomized controlled trial aims to evaluate the effectiveness and cost-effectiveness of a mobile-based psychoeducation prog...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. youths aged between 15 and 24 years old;
- • 2. exhibiting mild or above social phobia (i.e. Social Phobia Inventory score ≥ 25);
- • 3. having a smartphone with WeChat installed and basic internet literacy
- Exclusion Criteria:
- • 1. unable to attempt a baseline assessment (e.g., due to being unpermitted to leave a psychiatric ward);
- • 2. currently receiving another intensive psychological intervention;
- • 3. currently holding active suicidal plan;
- • 4. currently diagnosed with psychological disorders (e.g., schizophrenia, bipolar disorder, etc.).
About Hong Kong Shue Yan University
Hong Kong Shue Yan University (HKSYU) is a distinguished higher education institution dedicated to advancing knowledge and research in various fields, including health and social sciences. With a commitment to academic excellence and community service, HKSYU fosters innovative research initiatives aimed at addressing pressing health challenges. The university actively engages in clinical trials to enhance medical understanding and improve patient outcomes, leveraging its interdisciplinary expertise and collaboration with healthcare professionals. Through its rigorous research programs, HKSYU strives to contribute meaningfully to the global body of medical knowledge and the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Yizhou Wang, PhD
Principal Investigator
Hong Kong Shue Yan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported